Dr. Yasmina Mohammed Abd-Elhakim is an Associate Professor in the Forensic Medicine and Toxicology Department in the Faculty of Veterinary Medicine, Zagazig University, Egypt. Her major area of expertise is the use of eco-friendly mitigation strategies to combat the hazards of environmental pollutants. Additionally, she has a special interest in the therapeutic uses of arthropods venoms, particularly in neurodegenerative diseases and cancer. She has 60 papers in prestigious international journals and 2 book chapters, h-index 18, and more than 850 citations based on the Scopus database. She reviewed about 800 manuscripts for highly impacted journals in the field of toxicology and environmental pollution based on the Publon database. She has been included in the editorial board of several highly impacted international journals. She received various awards including The Egyptian State Encouragement Award in "Agricultural sciences" in 2019, the Publons peer reviewer award as a Top Reviewers for Pharmacology & Toxicology in 2018 and 2019, and the international publication's award from Zagazig University (2015-2019).
Dr. Mohd Adnan is an Associate Professor, Principal Investigator and Head of Academic Committee at Department of Biology, College of Science, University of Hail, Saudi Arabia. He did his PhD from University of Central Lancashire, UK; Master’s and Bachelor’s degree from Bangalore University, India; Post Graduate Diploma in Bioinformatics from SJAIT, India. He has more than 10 years of research, teaching and administrative experience. In his professional capacity, he has received various travel, observership and research grants as a Principal Investigator from various prestigious organizations.
He has successfully published 75+ publications in internationally recognized peer reviewed reputed journals, several book chapters for internationally renowned publishers and presented many papers and posters in various conferences/workshops globally. He has published widely in the field of phytomedicine, biofilms, drug discovery, natural products, nutraceuticals and functional foods with specialization in plant-based antibiofilm and anticancer agents, microbial biosurfactants, biofilms in food industry and medical settings, probiotics and cancer biology, novel biomolecules for/as health and antimicrobial agents.
He has reviewed 100+ manuscripts for 40+ internationally recognized peer-reviewed JCR journals and grant reviewer for many prestigious universities and organisations. In addition, he is a member of SFAM, UK and ESCMID, Switzerland and an Elected Member of Royal Society of Biology, UK. He also currently holds different editorial positions (Associate, Academic, Guest and Review Editor) in various esteemed journals and has edited 100+ manuscripts.
Ph.D. in Cellular & Clinical Neurobiology from Wayne State University School of Medicine. Associate Professor of Psychology at Minnesota State University, Mankato.
Dr. Abdulaziz Alzarea holds doctorate in Pharmaceutical Economics and Policy (Health Economics and Outcomes Research) and is currently serving as head of the Department of Clinical Pharmacy in Jouf University, Saudi Arabia. He has broad experience in Publishing related to Clinical Pharmacy, Pharmacy Practice, Pharmacoeconomics, Pharmacoepidemiology and outcomes research.
Dr. Usman Ali Ashfaq, Tenured Associate Professor of Molecular Biology and Group Leader, Health Biotechnology Group at the Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan. Dr. Usman Ali Ashfaq's expertise covers a range of subjects including, Molecular Biology, Virology, Molecular medicine, infectious diseases, integrated bioinformatics, Biotechnology and Genomics; more specifically his research covers the areas of diagnosis and treatment of infectious and metabolic diseases .
Dr Bagley is a Associate Professor in the Discipline of Pharmacology at the University of Sydney.
A/Prof Bagley completed a PhD at the University of Sydney in 2001. She was a C.J Martin Fellow from 2001 to 2006. During this time she was a postdoctoral fellow in the laboratory of Professor Gary Westbrook at the Vollum Institute (Oregon, USA) and at the Pain Management Research Institute (University of Sydney).
Dr Bagley began developing her research laboratory at the Brain and Mind Institute (2010-2011) and then moved to Pharmacology in 2011.
Davide Barreca is an Associate Professor of biochemistry at the University of Messina. He is specialized in enzyme modulation by natural compounds, inhibition of protein aggregation and activation of signal apoptotic cascade. Most of his research projects concentrate on separation and identification of unknown flavonoids, structural-activity elucidation, and biochemical analysis of their health promoting or cytotoxicity properties on cells culture. He is author of over 110 papers in peer-reviewed journals, 35 chapters in books, and 70 conference proceedings and reviewer of over 40 international scientific journals.
--- CURRENT POSITION ---
CEO of neurochlore and B ATherapeutics
--- EDUCATION ---
° 1973-1979 - Post-doctoral & sabbatical studies: University of Cambridge (UK), University of Oslo (Norway) and McGill University (Canada)
° 1971 - Doctorat ès-sciences, Université de Paris VI (France)
° 1966 - B Sc. Biochemistry-Physiology, Hebrew University of Jerusalem (Israel)
--- AWARDS ---
° 2014 - Finalist Créa13 -Neurochlore
° 2013 - Award « Tremplins de La Provence » - Neurochlore
° 2012 - Award of the of the FNRS ( Fonds de la Recherche Scientifique de Belgique) of Belgium
° 2010 - Award of the European Society of Epilepsy
° 2009 - Award of the Grand Prix de la Recherche médicale de l'INSERM
° 2009 - Docteur Honoris causae, Liège University (Belgium)
° 2006 - Rotary Brain Research Award
° 2002 - The Health Price (Grand Prix de la Santé) of the Foundation of French Electricity ° 2000 - The American Epilepsy Society Research Award for outstanding research in epilepsies
Dr. Glen Borchert holds joint appointments as an Assistant Professor in Biology and Pharmacology at the University of South Alabama. He originally received a B.S. in Biology from the University of Tennessee then completed a Ph.D. in Genetics from the University of Iowa. Dr. Borchert’s research focuses largely on identifying novel genetic regulators and defining their roles in oncogenesis, microbiology and speciation. Since starting his laboratory at South Alabama in August 2012, Dr. Borchert has published dozens of papers in peer reviewed journals and had numerous grant applications funded including a highly prestigious NSF CAREER award (2014-2019).
Minjun Chen is a principal investigator working at the Division of Bioinformatics and Biostatics of the US FDA’s National Center for Toxicological Research and serve as the adjunct faculty and mentor for the bioinformatics program joint by Univ. of Arkansas at Little Rock (UALR) and Univ. of Arkansas for Medical Sciences (UAMS). Currently, he co-chairs the FDA Liver Toxicity Working Group since 2014 and is the editor of the Springer book titled “Drug-induced Liver Toxicity”. His primary research interests encompass drug-induced liver injury, drug safety, bioinformatics, and personalized medicine. He has authored or co-authored more than 80 scientific publications and book chapters.
Chair and Professor, Pharmacology and Eric L. and Lila D. Nelson Chair in Neuropharmacology, School of Medicine, University of California, Irvine.
Professor of Pharmacology in the Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University. I study the cellular basis of opioid and cannabinoid receptor/ligand actions, with with the aim of better understanding their acute effects and the adaptations that occur after prolonged administration. This work has taken me to the University of Washington, University of Bristol, University of Sydney and the Vollum Institute before arriving at Macquarie. At the moment my lab focuses on the pharmacology of illicit synthetic cannabinoids and the molecular effects of phytocannabinoids.